AzTrials
AzTrials

Hypertension,EssentialFIHSTNCT04488289

The Föllinge Hypertension and Lifestyle Study

A study testing Lifestyle in people with Hypertension,Essential and Lifestyle-related Condition, run by Umeå University at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Ambulatory blood pressure measurement is more demanding in terms of technical equipment and specially trained staff. If blood pressure measurement in a self-care room is on average equivalent to the ambulatory blood pressure daytime monitoring of hypertension in primary care could be simplified. Read more about this study

Who is it for?
Ages 20 years and older
What is being tested?
Lifestyle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
117 participants
Where
1 siteSweden
Study dates
1 Feb 2021to 30 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 20 years or older
  • investigated or treated because of essential hypertension
  • registered at Föllinge Health Centre

Who cannot join

  • patients in need of emergency care
  • advanced stages of disease or dementia
  • not able to perform self-directed blood pressure measurement
  • pregnancy
  • atrial fibrillation
  • arm circumference to small or wide for device
  • non consenting
  • re entry in same study

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Gunnar Nilsson

    Östersund, Region Jämtland Härjedalen, 831 29

Other trials in Sweden

About this study

Official title: The Föllinge Hypertension and Lifestyle Intervention; a Comparative Study of Methods for Blood Pressure Measurement and Survey of Living Habits

Ambulatory blood pressure measurement is more demanding in terms of technical equipment and specially trained staff. If blood pressure measurement in a self-care room is on average equivalent to the ambulatory blood pressure daytime monitoring of hypertension in primary care could be simplified. We therefore want to examine patients monitored for hypertension (ICD 10) with three different methods: conventional blood pressure measurement in office, self-directed automated measurement and ambulatory blood pressure, starting in December 2020. We will also offer an interview covering cardiovascular risk factors, at time for enrollment and after 6 months. The study was approved to include 150 adult study patients (The swedish ethical review authority 2020-01375), men and women, where diagnosis and treatment of hypertension is relevant after a clinical evaluation.

Read the detailed description

Background: At present, both 24-hour ambulatory blood pressure and self-directed blood pressure measurement in self-care rooms, are services provided by most Swedish primary care clinics. Ambulatory measurement of blood pressure has the disadvantage of being more demanding with regard to the need for advanced technical equipment and trained staff.

Identification of modifiable cardiovascular risk factors and support for change, should be integrated into the treatment programs of hypertension. At study entry all study participants will be invited to an interview focused on identifying modifiable cardiovascular risk factors, with a follow-up interview after six months to consolidate good lifestyle choices.

Aim: If self-directed blood pressure measured in a designated self-care room gives results that are on average equivalent to ambulatory blood pressure daytime, diagnosis and follow-up of hypertensive patients in primary care could be simplified. The majority of patients could then be cared for through self-checks., and the technically more demanding ambulatory blood pressure measurement reserved for special cases. We therefore want to examine patients under treatment or investigated for hypertension in primary care with three different methods: conventional in-office blood pressure measurement by medical staff, ambulatory blood pressure and automated measurement of blood pressure in a special self-care room. Between study entry and after six months changes in modifiable risk factors are documented according to an interview guide covering use of tobacco, alcohol, physical activity and food preferences, with 4-6 fixed alternatives per item.

Demographics: Study patients are recruited among patients registered at Föllinge Health Centre (population 1500), of which about 1000 are in ages where investigation and treatment of hypertension could be relevant. The prevalence of hypertension in the adult population is estimated to about 30%.

Methods: We will recruit men and women from age 20 and older. Advanced age is not a criterion for exclusion if treatment of hypertension is judged to be important after clinical assessment.

Power calculation: Between-methods difference 4 mm Hg, standard deviation 15, correlation 0.4, nominal power 0.8, alpha 0.05: Least necessary number of pairwise measurements N = 135. Corresponding simulation as above, with an assumed correlation 0.5: Necessary number of pairwise measurements N =113. Based on the power calculation, we want to recruit up to 150 study patients for self-directed and office-based blood pressure measurement and ambulatory blood pressure, preliminarily starting in October 1 2020 and last enrolment December 30 2022.

Interview: An interview is offered to all study participants at enrolment and after about 6 months. The interview follows a risk factor inventory according to the Swedish Health Promotion and Healthcare Network, and the patient information pamphlet "Healthy choices make a difference".

Procedures: Potential study patients provide signed informed consent before enrolling in the study. Study patients are identified among patients who are evaluated or treated for hypertension. Study patients who have provided written informed consent are randomised for in-office and self-directed blood pressure measurement in random order on the day before and immediately after completing a 24-hour ambulatory blood pressure measurement.

Technical equipment: Blood pressure measurements are performed with Omron meters (automated oscillometry). In-office: Omron M7 Inteli IT (CE. 01997), certified for arm circumferences 22 - 42 cm. Self-care room: Omron i-Q142 (CE. 0197), certified for arm circumferences 22 - 42 cm. Ambulatory blood pressure measurement: Meditech ABPM-05 Blue BP-05 (CE 0120); cuff width 120 - 250 mm for 23 - 33 cm arm circumference and 150 - 330 mm, for 31 - 40 cm arm circumference.

Office blood pressure: Measurement after five minutes of rest in a quiet environment, with the patient sitting in a chair with a backrest and support for the arms. The blood pressure cuff is applied to the upper arm, at the level of the heart. Three measurements are performed at 1-2 minutes interval. Further measurements are made only if the first two values differ> 10 mm Hg. The blood pressure is recorded as the average of the last two measurements.

Blood pressure in a self-care room: The measurement is performed according to the same principles as in the office. The device signals if the patient does not handle it correctly. Simple instructions are clearly posted in the room. During measurement only one patient may stay in the self-care room at a time, without any staff present. Patients who need supervised instruction are offered guidance before measuring blood pressure on their own.

Ambulatory blood pressure: measurement every 30 minutes from 06 A.M.until 22 P.M. and every 60 minutes at night, for a total of 24 hours. The mean value 06 A.M.- 22 P.M is compared with the mean values for blood pressure measured in-office and in the self-care room respectively. All blood pressure measurements are performed in the left upper arm, to be able to compare with the corresponding values obtained in the self-care room, where the device is adapted for measurement in the left arm, while the patient handles the device's button control with the right hand.

Statistics: Standard numerical outcome measures, means and proportions for baseline variables, t-test and Chi-2, for means and group comparisons, respectively.

Standard blood and urine samples are analysed at the Department of Clinical Chemistry, Östersund Hospital. Potential study patients will undergo a medical examination, relevant biochemical analyses and an ECG recording (12-lead standard ECG) before enrolment in the study.

Importance of expected findings: Ambulatory blood pressure measurement has the disadvantage of being more demanding in terms of technical equipment and specially trained staff. If blood pressure measurement in a self-care room gives results that are equivalent to the ambulatory blood pressure values daytime, monitoring of hypertension in primary care could be simplified.

Being tested
Lifestyle
Medical subject headings
Essential Hypertension, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LifestyleOther

    Also called Lifestyle intervention

    Cardiovascular risk and lifestyle

Study groups in NCT04488289
Study groupRoleWhat they receive
Parallel measurement of blood pressureOtherOffice blood pressure, self-directed and ambulatory blood pressure measurement.
Receives: Other: Lifestyle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparative measurement of blood pressure

    Systolic and diastolic pressure, in office, self directed and ambulatory

    Measured: Hours 24

Secondary outcomes (1)
  1. Assessment of modifiable cardiovascular risk factors

    Modifiable risk factor scoring according to the questionnaire "Goda hälsoval gör skillnad" (www.hfsnatverket.se). Higher score indicating higher cardiovascular risk:

    Tobacco, cigarettes per day: never smoker; previous ≥6 months; previous <6 months; daily smoker 1-9; 10-14; 15-20; >20.

    Alcohol, standard glasses per week: abstainer; <1; 1-4; 5-9; 10-14; ≥15 per week. (One standard glass equals 33 cm of beer or cider, 15 cl of wine or 4 cl of spirits.) Binge drinking, standard glasses; men ≥5, women ≥4: Never; <1/month; every month; every week; daily or almost daily.

    Minutes of physic activity for at least 10 minutes, within 1 week: No; <30; 30-60; 60-90; 90-150; 150-300; > 300 minutes (5 hours or more).

    Consumption of vegetables (fresh, boiled or frozen) servings per day: ≥2; 1; 2-6 servings per week; ≤1 servings per week.

    Consumption of fruit (fresh, boiled or frozen) servings per day: ≥2; 1day; 2-6 servings per week; ≤1 servings per week.

    Measured: Months 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2020
  2. Study start1 Feb 2021
  3. Primary completion30 Dec 2023 (estimated)
  4. Study completion30 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
117 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04488289
Sponsor's protocol ID
2020-01375
Acronym
FIHST
Status last verified
Dec 2023
First submitted
15 Jul 2020
Last updated
8 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nilsson G, Lindam A. A comparative trial of blood pressure monitoring in a self-care kiosk, in office, and with ambulatory blood pressure monitoring. BMC Cardiovasc Disord. 2024 Jan 3;24(1):27. doi: 10.1186/s12872-023-03701-1.

    PubMed 38172659

Questions about this trial

What is this clinical trial studying?

A study testing Lifestyle in people with Hypertension,Essential and Lifestyle-related Condition, run by Umeå University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparative measurement of blood pressure (time frame: Hours 24). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04488289, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in